Keymed Bio-B Reports No Share Capital Changes for August 2026, Confirms Adequate Public Float

Bulletin Express09-02

Keymed Biosciences Inc. (Keymed Bio-B) filed its monthly return for the period ended 31 August 2026, indicating unchanged share capital metrics and continued compliance with Hong Kong’s public-float requirements.

• Authorised capital remained at 500.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to total authorised capital of USD 50,000. No adjustments were recorded during the month.

• Issued share count held steady at 298.74 million ordinary shares, all of which are listed on the Hong Kong Stock Exchange; the company carried no treasury shares.

• Keymed Bio-B confirmed that at month-end it satisfied the Main Board’s minimum public-float threshold of 25 percent of issued shares.

• The filing reported no activity in share option schemes, warrants, convertible securities or other equity-linked instruments.

The return was submitted on 2 September 2026 and signed by Executive Director Dr. Bo Chen.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1167342817?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-02 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167342817","market":"hk","top_or_hot":-1,"title":"Keymed Bio-B Reports No Share Capital Changes for August 2026, Confirms Adequate Public Float","media":"Bulletin Express","content":"<p>Keymed Biosciences Inc. (Keymed Bio-B) filed its monthly return for the period ended 31 August 2026, indicating unchanged share capital metrics and continued compliance with Hong Kong’s public-float requirements.</p>\n<p>• Authorised capital remained at 500.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to total authorised capital of USD 50,000. No adjustments were recorded during the month.</p>\n<p>• Issued share count held steady at 298.74 million ordinary shares, all of which are listed on the Hong Kong Stock Exchange; the company carried no treasury shares.</p>\n<p>• Keymed Bio-B confirmed that at month-end it satisfied the Main Board’s minimum public-float threshold of 25 percent of issued shares.</p>\n<p>• The filing reported no activity in share option schemes, warrants, convertible securities or other equity-linked instruments.</p>\n<p>The return was submitted on 2 September 2026 and signed by Executive Director Dr. Bo Chen.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Keymed Bio-B Reports No Share Capital Changes for August 2026, Confirms Adequate Public Float</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKeymed Bio-B Reports No Share Capital Changes for August 2026, Confirms Adequate Public Float\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-02 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Keymed Biosciences Inc. (Keymed Bio-B) filed its monthly return for the period ended 31 August 2026, indicating unchanged share capital metrics and continued compliance with Hong Kong’s public-float requirements.</p>\n<p>• Authorised capital remained at 500.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to total authorised capital of USD 50,000. No adjustments were recorded during the month.</p>\n<p>• Issued share count held steady at 298.74 million ordinary shares, all of which are listed on the Hong Kong Stock Exchange; the company carried no treasury shares.</p>\n<p>• Keymed Bio-B confirmed that at month-end it satisfied the Main Board’s minimum public-float threshold of 25 percent of issued shares.</p>\n<p>• The filing reported no activity in share option schemes, warrants, convertible securities or other equity-linked instruments.</p>\n<p>The return was submitted on 2 September 2026 and signed by Executive Director Dr. Bo Chen.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02162","symbol_name":"康诺亚-B","start_time":0,"source_url":"","article_id":"1167342817","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167342817","pubTimestamp":1788339834,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Keymed Biosciences Inc. (Keymed Bio-B) filed its monthly return for the period ended 31 August 2026, indicating unchanged share capital metrics and continued compliance with Hong Kong’s public-float...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02162":"康诺亚-B"},"translate_title":"Keymed Bio-B 报告 2026 年 8 月股本没有变化，确认有足够的公众持股量","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02162":1},"content_text":"Keymed Biosciences Inc. (Keymed Bio-B) filed its monthly return for the period ended 31 August 2026, indicating unchanged share capital metrics and continued compliance with Hong Kong’s public-float requirements.\n• Authorised capital remained at 500.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to total authorised capital of USD 50,000. No adjustments were recorded during the month.\n• Issued share count held steady at 298.74 million ordinary shares, all of which are listed on the Hong Kong Stock Exchange; the company carried no treasury shares.\n• Keymed Bio-B confirmed that at month-end it satisfied the Main Board’s minimum public-float threshold of 25 percent of issued shares.\n• The filing reported no activity in share option schemes, warrants, convertible securities or other equity-linked instruments.\nThe return was submitted on 2 September 2026 and signed by Executive Director Dr. Bo Chen.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1167342817","isCrawlerRequest":true}